Overview
Current Appointments & Affiliations
Professor of Pediatrics
·
2021 - Present
Pediatrics, Cardiology,
Pediatrics
Chief, Division of Pediatric Cardiology
·
2022 - Present
Pediatrics, Cardiology,
Pediatrics
Member in the Duke Clinical Research Institute
·
2012 - Present
Duke Clinical Research Institute,
Institutes and Centers
Associate of the Duke Initiative for Science & Society
·
2017 - Present
Duke Science & Society,
University Initiatives & Academic Support Units
In the News
View All News
Recent Publications
Methylprednisolone for Infant Heart Surgery: Subpopulation Analyses of a Randomized Controlled Trial.
Journal Article Crit Care Med · May 21, 2025 OBJECTIVES: Evaluate benefits and harms of prophylactic intraoperative methylprednisolone in subpopulations undergoing infant heart surgery. DESIGN: Subpopulation analyses of The Steroids to Reduce Systemic Inflammation after Infant Heart Surgery (STRESS) ... Full text Link to item CiteReexploring the STRESS Trial: Subgroup Postoperative Outcomes Following Methylprednisolone for Infant Heart Surgery.
Journal Article Pediatr Cardiol · May 2, 2025 UNLABELLED: Objective Assess the association between intraoperative methylprednisolone and specific postoperative outcomes among subgroups undergoing infant heart surgery. DESIGN: Subpopulation analyses of The Steroids to Reduce Systemic Inflammation after ... Full text Link to item CiteMethylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan Circulation.
Journal Article J Am Heart Assoc · April 2025 BACKGROUND: There is significant interest in NO pathway modulators, specifically type 5 phosphodiesterase inhibitors (PDE5is), to treat patients with a Fontan circulation. Trials, however, have had mixed results. The relationship between the NO pathway and ... Full text Link to item CiteRecent Grants
CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease
ResearchPrincipal Investigator · Awarded by Research Institute at Nationwide Children's Hospital · 2024 - 2030A PHASE 2/3 MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED AND OPEN-LABEL EXTENSION TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF AFICAMTEN IN A PEDIATRIC POPULATION WITH SYMPTOMATIC OBSTRUC
Clinical TrialPrincipal Investigator · Awarded by Cytokinetics, Inc. · 2025 - 2028Stimulating Access to Research in Residency (StARR) - NHLBI
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2018 - 2028View All Grants
Education, Training & Certifications
Wake Forest University ·
2002
M.D.